Legal 500
Log in or register
  • Rankings

    • Jurisdictions
    • Submissions
    • Future Lawyers
  • Firms & Lawyers

    • Service Providers
    • Barristers’ Sets
    • Networks
    • Interview with…
  • In-House

    • In-House Content
    • GC Powerlist
  • Knowledge Centre

    • Data Products
    • Legal Business
    • Market Intelligence
    • About us

      • Legal 500
      • FAQs
      • Marketing
      • Careers
      • Trust Centre
      • Contact us
  • Comparative Guides
  • Events
  • Legal 500 TV

About us

  • Legal 500
  • FAQs
  • Marketing
  • Careers
  • Trust Centre
  • Contact us
  • Deutschland DE
  • Paris FR
  • Rankings

    • Jurisdictions
    • Submissions
    • Future Lawyers
  • Firms & Lawyers

    • Service Providers
    • Barristers’ Sets
    • Networks
    • Interview with…
  • In-House

    • In-House Content
    • GC Powerlist
  • Knowledge Centre

    • Data Products
    • Legal Business
    • Market Intelligence
    • About us

      • Legal 500
      • FAQs
      • Marketing
      • Careers
      • Trust Centre
      • Contact us
  • Comparative Guides
  • Events
  • Legal 500 TV

About us

  • Legal 500
  • FAQs
  • Marketing
  • Careers
  • Trust Centre
  • Contact us
  • Deutschland DE
  • Paris FR

© 2026 Legalease Ltd. All rights reserved

Registered company in England & Wales No. 02427356 VAT GB 321 5727 22

Registered address: 188 Fleet Street, London, EC4A 2AG

  • Legal 500 Trust Centre
  • Contact Us
  • home
  • Market Intelligence
  • Search

442 results found

Use advanced search filters to refine your search

2 filters applied

Advanced search filters

Topics
Countries
Contributor

Start typing to add contributors

Content type
Show options
  • Article

    Patentability Of Genetically Modified Plant Breeds: The Monsanto Conclusion

    The apex court then went onto examine Section 64 of the Act, dealing with revocation of patents
    IndiaIntellectual Property
    Khurana & Khurana, Advocates and IP Attorneys
    Khurana & Khurana, Advocates and IP Attorneys
  • Article

    Pharmaceutical Trademark And Its Conflict With Trademark Law

    Out of the many trademarks registered every year, the Indian pharmaceutical industry accounts for a major portion compared to the other sectors.
    IndiaIntellectual Property
    Khurana & Khurana, Advocates and IP Attorneys
    Khurana & Khurana, Advocates and IP Attorneys
Article

ANGEL TAX: The Story Continues

A lot of voices have been raised against an Income Tax Act amendment, which came to be popularly known as the "angel tax". The Department of Industrial Policy and Promotion (DIPP) issued a notification
IndiaTax
JoyceLaw
JoyceLaw
  • Article

    DNA Fingerprinting Results Allowed In Plant Variety Disputes

    Evidence from DNA fingerprinting tests can be used to determine disputes involving plant varieties, according to a recent decision of the Delhi High Court. In its recent judgment
    IndiaFood, Drugs, Healthcare, Life Sciences
    Obhan Mason
    Obhan Mason
  • Article

    Ministry Of Health Prohibits Antibody Detecting Rapid Diagnostic Tests For Routine Diagnosis Of Malaria

    On March 23, 2018, the Ministry of Health and Family Welfare, Government of India, has, in public interest, prohibited the use of ADRDT for routine diagnosis of malaria with immediate effect.
    IndiaFood, Drugs, Healthcare, Life Sciences
    S&A Law Offices
    S&A Law Offices
  • Article

    Novartis's Kisqali® (Ribociclib) Received FDA Breakthrough Therapy Designation

    On January 03, 2018, Novartis announced that KisqaliR (Ribociclib) has received FDA Breakthrough Therapy designation for initial endocrine-based treatment, in combination with tamoxifen or an aromatase inhibitor,...
    IndiaFood, Drugs, Healthcare, Life Sciences
    S&A Law Offices
    S&A Law Offices
  • Article

    Companies CSR Amendment 2020

    Last year, in November 2019, a High- Level Committee (HLC) on Corporate Social Responsibility (CSR) was set up to review the CSR framework and make recommendations for developing a more robust...
    IndiaCorporate/Commercial Law
    HSA Advocates
    HSA Advocates
  • Article

    Fixation Of Prices Of Drugs Under The DPCO , 2013: Application Of Para 19 Only In Extra-Ordinary Circumstances

    Indian Pharmaceutical Industry is at present, at its most progressive era where it has witnessed a robust growth over the past few years.
    IndiaFood, Drugs, Healthcare, Life Sciences
    S&A Law Offices
    S&A Law Offices
  • Article

    Food & Pharma Flash - October 2014

    The government would initially allocate Rs.500 crore between all the pharma funds to be set up under this project.
    IndiaFood, Drugs, Healthcare, Life Sciences
    PSA
    PSA
  • Article

    Risk Classification Of Medical Devices And IVDs Published! Countdown For January 1, 2018 Begins!

    On November 1, 2017, India's central medical device regulator, the Central Drugs Standards Control Organization, published a revised risk classification of medical devices and IVDs...
    IndiaFood, Drugs, Healthcare, Life Sciences
    Nishith Desai Associates
    Nishith Desai Associates
  • Article

    The National Medical Devices Policy, 2023 – A List Of Resolutions

    On April 26, 2023, the Union Cabinet approved the National Medical Devices Policy, 2023.
    IndiaFood, Drugs, Healthcare, Life Sciences
    Obhan Mason
    Obhan Mason
  • Article

    US FDA Highlights July 2019

    This segment discusses the recent drug approvals from the US FDA in various severe diseases. The write-ups describe the role of a new drug in the treatment of serious conditions such as myeloma
    IndiaFood, Drugs, Healthcare, Life Sciences
    S&A Law Offices
    S&A Law Offices
  • Article

    Bolar Exemption: A Good Defense Against Pharmaceutical Patent Infringement Under Indian Patents Act

    This article elaborates the concept of Bolar Exemption, also known as Bolar provision, under the Indian Patent Act, 1970 (hereinafter called as Act).
    IndiaIntellectual Property
    S&A Law Offices
    S&A Law Offices
  • Article

    Enantiomer Patents: Non Obviousness In Secondary Pharmaceutical Patents

    ‘Stereochemistry' is the study of spatial arrangements of atoms in a molecule. A molecule may be similar in chemical makeup to another molecule, however, the spatial arrangements of ...
    IndiaIntellectual Property
    Khurana & Khurana, Advocates and IP Attorneys
    Khurana & Khurana, Advocates and IP Attorneys
  • Article

    Federal Circuit Rules 180-Day Post-Licensure Notice Is Mandatory In Biosimilar Litigation

    If the parties reach agreement, then the reference product sponsor must bring an infringement action within 30 days for each patent on the negotiated list.
    IndiaIntellectual Property
    Khurana & Khurana, Advocates and IP Attorneys
    Khurana & Khurana, Advocates and IP Attorneys
  • Article

    Interpretation Of Section 8 Of Indian Patents Act In Koninklijke Philips vs Sukesh Behl Case

    The importance of Section 8 requirement of the Indian Patents Act, 1970 was felt in the case of Chemtura Corp vs Union of India where it was strictly enforced.
    IndiaIntellectual Property
    S&A Law Offices
    S&A Law Offices
  • Article

    Natco Pharma Obtains Compulsory Licence To Manufacture Bayer's Patented 'Naxavar' Anti-Cancer Drug

    In an eagerly awaited decision, India's Controller of Patents has granted a licence to generics pharmaceutical manufacturer, Natco Pharma Ltd (Natco) to manufacture Bayer's patented anticancer drug 'Naxavar'.
    IndiaIntellectual Property
    Rouse
    Rouse
  • Article

    Position Trademarks In The Pharmaceutical Industry

    There are a lot of brands that have acquired popularity and distinctiveness based on the way their labels and logos are placed on a given product. But did you know that these brands...
    IndiaIntellectual Property
    Maheshwari & Co. Advocates & Legal Consultants
    Maheshwari & Co. Advocates & Legal Consultants
  • Article

    Second Medical Use-Patents

    The idea that previously discovered chemicals and compositions may be used to discover novel functions, capacities, or medicinal applications is certainly intriguing.
    IndiaIntellectual Property
    S&A Law Offices
    S&A Law Offices
  • Article

    Mashelkar Committee Withdraws Its Report

    In an unprecedented twist in the legislative process, the Technical Expert Group on Patent Law Issues requested the Government of India to withdraw its Report that was submitted by the Group on December 29, 2006. The Government of India constituted the Expert Group in April 2005 in a follow up of the issues raised in the Parliament during the debate on Patent (Amendment) Bill, 2005.
    IndiaIntellectual Property
    Lex Orbis
    Lex Orbis
  • Showing 181–200 of 442 results

    PreviousNext
    Legal Intelligence Newsletters: sign up for the latest legal and regulatory news on your chosen topics